Register for Upcoming Webinar on DEC. 8 @ 11AM
2024 China NMPA Bluebook is here:
If you need to provide feedback to CFDA, please let us know and we will consolidate and send it for you. Please email to . If you want to email
I am sharing a response I posted to a question by a manufacturer RA. The Guideline was issued on Sept 21 for further feedback and asked all feedback be emailed
Next week is a long national holiday in China, celebrating the founding of People’s Republic of China in 1949. My inbox will slow down but I know a lot of
Since 2015, more than 100 regulations and laws have passed from the central government mandates to CFDA requirements biggest shakeup since 2000. The changes impact not only premarket submission but
Companies in non-healthcare industry in China are eager to get into healthcare sector from both supply and demand side. Pharmaceutical companies in China are eager to diversity and transform its
The Investment Trends Report of The 17 Segment Diseases In Recent 20 Years USAThe slowdown in 20 years of US medtech investment in 17 diseases has become the windfall to
Several key factors suggest that China medical device industry continues to be attractive for both China domestic investors and manufacturers from pharmaceutical and other industries as well as the medtech
March 15th, 2016 China is ranked #2 in national GDP in the world in 2015, almost 3 times of Japan. It is one of the world’s fastest-growing markets for medical
December 22nd, 2015 Thank you for your support and trust in China Med Device Group to contribute to the funding and commercialization of medical device companies between the U.S. and
October 5th, 2015 Grace Fu Palma, CEO of China Med Device (www.chinameddevice.com), successfully moderates the panel on China Healthcare System at the New England Healthcare Executive Meeting on October 5th,
Email: info@chinameddevice.com
Phone: 978-390-4453
USA Office:
1 Broadway, 14th Floor
Cambridge, MA 02142
CHINA Office:
Suite 1702C, Beijing Hailongshiyou Building, Chaoyang District, Beijing